Tag: development

Preclinical data demonstrate enhanced systemic exposure and bioavailability, reduced dermal toxicity, and improved safety profile in ALT-B4-enabled ADC therapyKey PointsSuperior PK: Subcutaneous administration of ADCs...

Telenor has agreed to acquire Enivest, one of the leading fibre operators in Western Norway, in a transaction valued at NOK 2.5 billion

A new cellulose-based material platform developed in Finland responds to tightening regulatory requirements and industry pressure to both replace and reduce plastic in packaging,...

SHANGHAI, June 10, 2026 /PRNewswire/ -- Trinasolar, a global leader in smart PV and energy storage solutions, has signed a Memorandum of Understanding (MoU)...

New TVC on ARD and ZDF delivers how quiet discipline drives both elite sport and autonomous lawn care.DÜSSELDORF, Germany, June 10, 2026 /PRNewswire/ --...

WeRide outlined plans to commercialize its L4 AV portfolio in Slovakia during a meeting with His Excellency Mr. Robert Fico Prime Minister of Slovakia.

New platform uses automation and predictive insights to streamline IT operations and reduce downtimeLONDON, June 10, 2026 /PRNewswire/ -- As the AI Summit London brings...

Edmonton-born PropTech company draws property managers, investors, real estate operators, technology leaders, government representatives, academia, community leaders, and media to unveil the future of AI-assisted property operations

Edmonton-born PropTech company draws property managers, investors, real estate operators, technology leaders, government representatives, academia, community leaders, and media to unveil the future of AI-assisted property operations

AUSTIN, Texas and DURHAM, N.C., June 10, 2026 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (“Shattuck” or the “Company”) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of potentially first-in-class monoclonal and bispecific DR3 blocking antibodies for the treatment of patients with inflammatory and immune-mediated diseases, today announced the pricing of its previously announced a public offering of 10,879,376 shares of its common stock at a public offering price per share of $4.00 and, in lieu of common stock to certain investors, pre-funded warrants to purchase up to 7,870,624 shares of its common stock at a public offering price of $3.9999 per pre-funded warrant. The pre-funded warrants have an exercise price of $0.0001 per share and are exercisable immediately. The aggregate gross proceeds to Shattuck from the offering are expected to be approximately $75 million before deducting underwriting discounts and commissions and other offering expenses payable by Shattuck, excluding any exercise of the underwriters’ option to purchase additional shares. The offering is expected to close on June 11, 2026, subject to the satisfaction of customary closing conditions. In addition, Shattuck has granted the underwriters an option for a period of 30 days to purchase up to an additional 2,812,500 shares of its common stock at the public offering price, less underwriting discounts and commissions.

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, June 10, 2026 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the...

ISTANBUL, June 10, 2026 /PRNewswire/ -- Zoomlion Heavy Industry Science & Technology Co., Ltd. ("Zoomlion") attracted widespread attention at KOMATEK 2026 in Istanbul with...

TAIPEI, June 10, 2026 /PRNewswire/ -- HKC, ANTGAMER, and KOORUI have successfully concluded their presence at COMPUTEX 2026. Under the theme "Win Beyond the...